期刊文献+

高效液相色谱法测定西罗莫司血药浓度

HPLC Method for the Determination of Sirolimus in Human Plasma
下载PDF
导出
摘要 目的:建立快速测定人全血中西罗莫司浓度的高效液相色谱方法。方法:色谱柱为Zorbax Eclipse XDB C18(4.6mm×150mm,5μm);流动相为甲醇-乙腈-去离子水(50∶22∶28,v/v);流速1.2mL.min-1;紫外检测波长278nm;柱温50℃。结果:西罗莫司浓度测定的线性范围为2.5~50.0μg.L-1,最低检测浓度为2.0μg.L-1,平均回收率为103.2%,日内RSD小于5%,日间RSD小于4%。结论:本方法简便、快速,定量准确,可用于西罗莫司临床药动学研究,也可用于西罗莫司常规血药浓度监测。 Objective: To establish a rapid and feasible high-performance liquid chromatographic(HPLC) method for the determination of Sirolimus(SRL) in human plasma.Methods: Prior to analysis,SRL was isolated from plasma sample using ultra filtration.The extracts were injected onto an Zorbax Eclipse XDB C18(4.6 mm×150 mm,5 μm) column at 50℃ with detection UV wavelengths set at 278 nm.The mobile phase was consisted of Meth-ACN-H2O(50∶22∶28,v/v),at a flow rate of 1.2 mL·min-1.Result: Calibration curves were linear over a concentration range of 2.5~50.0 μg·mL-1 for SRL.The average recoveries of SRL were 103.2%.The within-day precision and between-day precision of SRL were less than 5% and 4%.Conclusion: This method is simple,quick and accurate and can be used for routine monitoring and clinical study of SRL pharmacokinetics.
出处 《药学与临床研究》 2010年第6期580-582,共3页 Pharmaceutical and Clinical Research
关键词 西罗莫司 血药浓度 高效液相色谱法 Sirolimus(SRL) Blood concentration HPLC
  • 相关文献

参考文献5

  • 1季曙明.雷帕霉素免疫抑制作用机制的研究进展[J].肾脏病与透析肾移植杂志,2001,10(5):483-486. 被引量:11
  • 2Andrade MC,Di Marco GS,Felipe CR,et al.Sirolimus quantification by high-performance liquid chromatography with ultraviolet detection[J].Transpl Int,2005,18(3):354-9.
  • 3Di Marco GS,de Andrade MC,Felipe CR,et al.Determination of sirolimus blood concentration using high-performance liquid chromatography with ultraviolet detection[J].Ther Drug Monit,2003,25(5):558-64.
  • 4Khoschsorur G.Simultaneous measurement of sirolimus and everolimus in whole blood by HPLC with ultraviolet detection[J].Clin Chen.2005,51(9):1721-4.
  • 5徐红冰,胡道德,陈桂良,谭建明,唐孝达.HPLC法检测肾移植病人全血中西罗莫司的药物浓度[J].药学服务与研究,2004,4(2):152-154. 被引量:3

二级参考文献10

  • 1[2]Groth CG, Backman L, Morles JM, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation:similar efficacy and different toxicity compared with cyclosporine. Sirolimus European renal transplant study group [J]. Transplantation, 1999, 67 (7): 1036.
  • 2[4]Maleki S, Graves S, Becker S, et al. Therapeutic monitoring of sirolimus in human whole-blood samples by highperformance liquid chromatography[J]. Clin Ther, 2000, 22(Suppl B): B25.
  • 3[5]Salm P,Taylor PJ,Pillans PI. The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and micropartical enzyme immunoassay in renal transplant recipients[J]. Clin Ther, 2000,22 (Suppl B): B71.
  • 4Chung J,Cell,1992年,69卷,1227页
  • 5Mc Alister V C,Lancet,2000年,355卷,376页
  • 6Qi S,Microsurg,1999年,19卷,344页
  • 7Hong J C,Trans plantation,1999年,68卷,701页
  • 8Kahan B D,Trans plantation,1991年,51卷,232页
  • 9季曙明.雷帕霉素免疫抑制作用机制的研究进展[J].肾脏病与透析肾移植杂志,2001,10(5):483-486. 被引量:11
  • 10季曙明,尹广,陈劲松,殷立平,沙国柱,周虹,黎磊石.雷帕霉素联合环孢素A预防肾移植急性排斥反应[J].肾脏病与透析肾移植杂志,2003,12(2):132-135. 被引量:8

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部